| Efficacy of weight loss intervention can be predicted based on early alterations of fMRI food cue reactivity in the striatum P Hermann, V Gál, I Kóbor, CB Kirwan, P Kovács, T Kitka, Z Lengyel, ... NeuroImage: Clinical 23, 101803, 2019 | 41 | 2019 |
| Small platform sleep deprivation selectively increases the average duration of rapid eye movement sleep episodes during sleep rebound T Kitka, Z Katai, D Pap, E Molnar, C Adori, G Bagdy Behavioural brain research 205 (2), 482-487, 2009 | 31 | 2009 |
| Association between the activation of MCH and orexin immunorective neurons and REM sleep architecture during REM rebound after a three day long REM deprivation T Kitka, C Adori, Z Katai, S Vas, E Molnar, RS Papp, ZE Toth, G Bagdy Neurochemistry international 59 (5), 686-694, 2011 | 28 | 2011 |
| Acute escitalopram treatment inhibits REM sleep rebound and activation of MCH-expressing neurons in the lateral hypothalamus after long term selective REM sleep deprivation Z Kátai, C Ádori, T Kitka, S Vas, L Kalmár, D Kostyalik, L Tóthfalusi, ... Psychopharmacology 228, 439-449, 2013 | 25 | 2013 |
| Acute 5-HT2C Receptor Antagonist SB-242084 Treatment Affects EEG Gamma Band Activity Similarly to Chronic Escitalopram N Papp, S Koncz, D Kostyalik, T Kitka, P Petschner, S Vas, G Bagdy Frontiers in Pharmacology 10, 1636, 2020 | 18 | 2020 |
| Abundance and location of DARPP-32 in striato-tegmental circuits of domestic chicks E Bálint, T Kitka, G Zachar, A Adám, HC Hemmings Jr, A Csillag Journal of Chemical Neuroanatomy 28 (1-2), 27-36, 2004 | 17 | 2004 |
| Chronic escitalopram treatment attenuated the accelerated rapid eye movement sleep transitions after selective rapid eye movement sleep deprivation: a model-based analysis … D Kostyalik, S Vas, Z Kátai, T Kitka, I Gyertyán, G Bagdy, L Tóthfalusi BMC neuroscience 15, 1-16, 2014 | 14 | 2014 |
| MDMA treatment 6 months earlier attenuates the effects of CP-94,253, a 5-HT1B receptor agonist, on motor control but not sleep inhibition N Gyongyosi, B Balogh, E Kirilly, T Kitka, S Kantor, G Bagdy Brain research 1231, 34-46, 2008 | 14 | 2008 |
| Procognitive profiling of a serotonin 5-HT6 receptor antagonist in a complex model system in rats: A novel translational approach for clinical prediction I Gyertyán, F Kassai, T Kitka, AJ Ernyey Brain Research Bulletin 165, 238-245, 2020 | 12 | 2020 |
| Recent patents on novel MCH1 receptor antagonists as potential anti-obesity drugs K K Szalai, G Beke, J Éles, T Kitka, P Kovács, J Nagy, S Farkas, A Boros Recent Patents on CNS Drug Discovery (Discontinued) 9 (2), 122-140, 2014 | 9 | 2014 |
| Effect of 5-HT2A/2B/2C receptor agonists and antagonists on sleep and waking in laboratory animals and humans T Kitka, G Bagdy Serotonin and sleep: molecular, functional and clinical aspects, 387-414, 2008 | 7 | 2008 |
| Differential regulation of metabolic parameters by energy deficit and hunger T Kitka, S Tuza, B Varga, C Horváth, P Kovács Metabolism 64 (10), 1235-1239, 2015 | 6 | 2015 |
| Topiramate inhibits adjuvant-induced chronic orofacial inflammatory allodynia in the rat V Mohos, M Harmat, J Kun, T Aczél, BZ Zsidó, T Kitka, S Farkas, E Pintér, ... Frontiers in Pharmacology 15, 1461355, 2024 | | 2024 |
| Chemogenetic inhibition of the lateral hypothalamus effectively reduces food intake in rats in a translational proof-of-concept study P Kovács, T Kitka, ZK Bali, LV Nagy, A Bodó, T Kovács-Öller, Z Péterfi, ... Scientific Reports 14 (1), 11402, 2024 | | 2024 |
| Chemogenetic inhibition of the lateral hypothalamus in rats: A simple but robust tool with high translational relevance to facilitate the development of central nervous system … P Kovács, T Kitka, ZK Bali, LV Nagy, A Bodó, Z Péterfi, I Hernádi | | 2023 |
| Therapeutic combination of memantine and baclofen and pharmaceutical composition containing them P Kovács, T Kitka, M Misnyovszki, B Varga, S Farkas, CM Horváth | | 2014 |
| Combinación terapéutica de memantina y baclofeno y composición farmacéutica que los contiene P Kovács, T Kitka, M Egyed-Misnyovszki, B Varga, S Farkas, CM Horváth | | 2014 |
| Combinacion que comprende memantina y baclofeno; composicion farmaceutica que la comprende; y uso en el tratamiento del sobrepeso y la obesidad. P Kovacs, T Kitka, M Misnyovszki, S Farkas, CM Horvath, B Varga | | 2014 |
| Therapeutic combination of memantine and baclofen and pharmaceutical composition containing them P Kovács, T Kitka, M MISNYOVSZKI, B Varga, S Farkas, CM Horvath | | 2013 |
| Association between the Activation of Melanin‐concentrating Hormone (MCH) Producing Neurons and REM Sleep in Rats S Vas, D Kostyalik, Z Katai, T Kitka, C Adori, E Molnar, P Petschner, D Pap, ... The FASEB Journal 26, lb700-lb700, 2012 | | 2012 |
István Gyertyángroup leader, MTA-SE NAP B Cognitive Translational Behavioural Pharmacology Group, Semmelweis University 在 med.semmelweis-univ.hu 的电子邮件经过验证
István Gyertyángroup leader, MTA-SE NAP B Cognitive Translational Behavioural Pharmacology Group, Semmelweis University 在 med.semmelweis-univ.hu 的电子邮件经过验证